囊袋张力环植入对人工晶状体旋转稳定性影响的荟萃分析
结果显示CTR组IOL平均绝对旋转角度显著更低,旋转>5°和>10°的比例显著降低,残余散光显著更低,但视力无显著改善,术后并发症无显著差异。
要点
- CTR联合植入显著降低IOL平均绝对旋转角度(SMD=-0.45)。
- CTR组IOL旋转>5°和>10°比例显著低于非CTR组。
- CTR组术后残余散光显著更低,但视力无显著改善。
核心结论
- 联合植入CTR术后安全性良好,能显著提高IOL旋转稳定性并有效减少术后残余散光,但对视力改善作用不显著。
研究设计与样本
- 荟萃分析,系统检索PubMed、Web of Science、Embase、CENTRAL、Google Scholar及中国知网、万方、维普数据库,检索时间自建库至2025年6月。
- 采用Cochrane偏倚风险评估工具2.0和改良纽卡斯尔-渥太华量表评估研究质量,使用R软件计算SMD或RR及其95%CI。
主要发现
- 末次随访时CTR组IOL平均绝对旋转角度显著小于非CTR组(SMD=-0.45,95%CI:-0.72~-0.17,P=0.002),研究间异质性显著(I2=80.8%,P<0.001)。
- CTR稳定作用术后1周不显著(P=0.084),术后1个月开始显著(SMD=-0.48,95%CI:-0.79~-0.18,P=0.002)并持续至6个月及以上(SMD=-0.52,95%CI:-0.99~-0.04,P=0.033)。
- CTR组IOL旋转>5°(RR=0.50,95%CI:0.32~0.78,P=0.002)和>10°(RR=0.37,95%CI:0.17~0.81,P=0.014)的患者比例显著低于非CTR组,旋转>15°比例差异无统计学意义(P>0.05)。
- 亚组分析显示亚洲研究较欧洲研究CTR获益更显著(P<0.001),平板襻IOL较C襻IOL旋转稳定性改善更明显(P<0.001)。
- 两组UDVA、CDVA和UNVA差异均无统计学意义(均P>0.05),CTR组术后残余散光显著低于非CTR组(SMD=-0.86,95%CI:-1.40~-0.32,P=0.002)。
关键数值与推荐
- 主要结局指标为术后IOL平均绝对旋转度数及旋转>5°、>10°和>15°的患者比例。
- 次要结局指标为UDVA、CDVA、UNVA、残余散光及术后并发症发生率。
- 术后并发症方面,两组后囊膜混浊、前囊膜混浊及眼压升高的发生率差异均无统计学意义(均P>0.05)。
临床怎么用
- 对需要提高IOL旋转稳定性的白内障手术患者,可考虑联合植入CTR以减少IOL旋转和残余散光。
- CTR对旋转稳定性的获益在术后1个月起显著并持续至6个月及以上,术后早期1周内效果不显著。
- 亚洲人群及使用平板襻IOL的患者可能从CTR联合植入中获益更明显。
局限性
- 纳入研究间存在显著异质性(I2=80.8%,P<0.001)。
- 纳入15篇文献中仅5篇为随机对照试验,其余10篇为非随机研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To systematically evaluate the influence of capsular tension ring (CTR) co-implantation on the rotational stability of intraocular lenses (IOLs) following cataract surgery. Methods: A systematic search was conducted in PubMed, Web of Science, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, and Chinese databases (CNKI, Wanfang, VIP) for randomized controlled trials (RCTs) and non-randomized studies comparing postoperative IOL rotational stability with and without CTR implantation, from inception to June 2025. The primary outcomes were mean absolute IOL rotation and the proportions of eyes with IOL rotation>5°,>10°, and >15°. Secondary outcomes included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), residual astigmatism (RAS), and postoperative complications. Study quality was assessed using the Cochrane Risk of Bias tool 2.0 (RoB 2.0) for RCTs and the modified Newcastle-Ottawa Scale (NOS) for non-randomized studies. Meta-analysis was performed using R software to calculate standardized mean difference (SMD) or relative risk (RR) with 95% confidence intervals (CI). Results: A total of 15 studies (5 RCTs and 10 non-randomized studies) involving 1 536 eyes were included (CTR group: 796 eyes, non-CTR group: 740 eyes), with follow-up durations ranging from 3 to 12 months. At the final follow-up, the mean absolute IOL rotation was significantly lower in the CTR group than in the non-CTR group (SMD=-0.45, 95%CI:-0.72 to -0.17, P=0.002), with significant heterogeneity among studies (I2=80.8%, P<0.001). Time-trend analysis showed that the stabilizing effect of CTR was not significant at 1 week postoperatively (P=0.084), but became significant at 1 month (SMD=-0.48, 95%CI:-0.79 to -0.18, P=0.002) and persisted through 6 months or longer (SMD=-0.52, 95%CI:-0.99 to -0.04, P=0.033). The proportions of eyes with IOL rotation>5° (RR=0.50, 95%CI: 0.32 to 0.78, P=0.002) and>10° (RR=0.37, 95%CI: 0.17 to 0.81, P=0.014) were significantly lower in the CTR group, whereas no significant difference was found for rotation>15° (P>0.05). Subgroup analyses revealed that the beneficial effect of CTR was more pronounced in Asian populations compared with European populations (P for interaction <0.001) and in plate-haptic IOLs compared with C-loop IOLs (P for interaction<0.001). Regarding visual and refractive outcomes, no significant differences were observed between the two groups in UDVA, CDVA, or UNVA (all P>0.05), whereas postoperative RAS was significantly lower in the CTR group (SMD=-0.86, 95%CI:-1.40 to -0.32, P=0.002). No significant differences were found in the incidence of posterior capsule opacification, anterior capsule opacification, or elevated intraocular pressure between the groups (all P>0.05). Conclusion: Co-implantation of a CTR demonstrates good postoperative safety, significantly enhances IOL rotational stability, and effectively reduces postoperative residual astigmatism, though it does not lead to a significant improvement in visual acuity. 目的: 探讨囊袋张力环(CTR)植入对白内障术后人工晶状体(IOL)旋转稳定性的影响。 方法: 荟萃分析。系统检索PubMed、Web of Science、Embase、Cochrane对照试验中心注册库(CENTRAL)、Google Scholar及中国知网、万方、维普数据库中比较CTR植入与否对白内障术后IOL旋转稳定性影响的随机对照试验及非随机对照研究,检索时间自建库至2025年6月。主要结局指标为术后IOL平均绝对旋转度数,以及术后IOL旋转>5°、>10°和>15°的患者比例。次要结局指标为裸眼远视力(UDVA)、矫正远视力(CDVA)、裸眼近视力(UNVA)、残余散光(RAS)及术后并发症发生率。采用Cochrane偏倚风险评估工具2.0和改良纽卡斯尔-渥太华量表评估研究质量。使用R软件进行荟萃分析,计算标准化均差(SMD)或相对危险度(RR)及其95%置信区间(CI)。 结果: 最终纳入15篇文献(5篇随机对照试验,10篇非随机研究),共1 536只眼,其中CTR组796只眼,非CTR组740只眼,纳入研究随访时间为3~12个月。末次随访时,CTR组IOL平均绝对旋转角度显著小于非CTR组(SMD=-0.45,95%CI:-0.72~-0.17,P=0.002),但各研究间存在显著异质性(I2=80.8%,P<0.001)。时间趋势分析显示,CTR的稳定作用在术后1周不显著(P=0.084),术后1个月开始显著(SMD=-0.48,95%CI:-0.79~-0.18,P=0.002)并持续至6个月及以上(SMD=-0.52,95%CI:-0.99~-0.04,P=0.033)。CTR组IOL旋转>5°(RR=0.50,95%CI:0.32~0.78,P=0.002)和>10°(RR=0.37,95%CI:0.17~0.81,P=0.014)的患者比例显著低于非CTR组,两组IOL旋转>15°的比例差异无统计学意义(P>0.05)。亚组分析显示,亚洲研究较欧洲研究CTR获益更显著(P<0.001),平板襻IOL较C襻IOL旋转稳定性改善更明显(组间差异P<0.001)。视力和屈光方面,两组UDVA、CDVA和UNVA差异均无统计学意义(均P>0.05),CTR组术后RAS显著低于非CTR组(SMD=-0.86,95%CI:-1.40~-0.32,P=0.002)。术后并发症方面,两组后囊膜混浊、前囊膜混浊及眼压升高的发生率差异均无统计学意义(均P>0.05)。 结论: 联合植入CTR的术后安全性良好,且能显著提高IOL的旋转稳定性并有效减少术后残余散光,但对视力的改善作用不显著。.
引用
- Liu DH, Hu LX, Qin R, et al. [Influence of capsular tension ring implantation on rotational stability of intraocular lenses: a meta-analysis]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 41946595. doi:10.3760/cma.j.cn112142-20251130-00506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。